← Back to Search

Joyuus App for Postpartum Care

N/A
Recruiting
Research Sponsored by Joyuus, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must be age 18 or older
Must be between 0-6 months postpartum
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change between baseline and 12 months
Awards & highlights

Study Summary

This trial is testing whether Joyuus improves maternal functioning in postpartum moms. Results will measure depression, anxiety, resilience, social support, and knowledge.

Who is the study for?
This trial is for women aged 18 or older who are within 0-6 months postpartum, have a smartphone with internet, and can speak, read, and write in English. It's not for those with health issues affecting their participation or who didn't have a live birth.Check my eligibility
What is being tested?
The study compares the Joyuus self-care mobile app to standard care in improving maternal functioning after childbirth. It checks if the app helps more with mood, resilience, support, and knowledge over follow-ups at 3-, 6-, and 12-weeks.See study design
What are the potential side effects?
Since this trial involves using a web-based tool rather than medication or medical procedures, traditional side effects aren't expected. However, users may experience stress or frustration if technical issues arise.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I gave birth within the last 6 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change between baseline and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and change between baseline and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Barkin Index of Maternal Functioning (BIMF)
Secondary outcome measures
Connor-Davidson Resilience Scale (CDRS)
Edinburgh Postnatal Depression Scale (EPDS)
State-Trait Anxiety Inventory (STAI)
Other outcome measures
COVID-19 and Mental Health Impacts Scale
Maternal Health Knowledge

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: active intervention groupExperimental Treatment1 Intervention
Participants will receive immediate access to Joyuus selfcare mobile app
Group II: standard care control groupActive Control1 Intervention
Participants will receive standard care, and will not have access to Joyuus selfcare mobile app until study completion.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,696 Previous Clinical Trials
6,952,447 Total Patients Enrolled
1 Trials studying Maternal Health
300 Patients Enrolled for Maternal Health
Joyuus, LLCLead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)NIH
381 Previous Clinical Trials
1,215,924 Total Patients Enrolled

Media Library

Joyuus Self-care Mobile App Clinical Trial Eligibility Overview. Trial Name: NCT05876559 — N/A
Maternal Health Research Study Groups: active intervention group, standard care control group
Maternal Health Clinical Trial 2023: Joyuus Self-care Mobile App Highlights & Side Effects. Trial Name: NCT05876559 — N/A
Joyuus Self-care Mobile App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05876559 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any particular demographics that are ideal candidates for this research study?

"Eligibility requirements for this medical research state that participants should have maternal health and be aged between 18 to 99 years old. A total of 132 people will be accepted into the trial."

Answered by AI

Are there any vacancies available for enrollment in this clinical trial?

"Evidently, this clinical trial is no longer recruiting patients. Initially posted on October 1st 2023 and most recently updated on May 24th 2023; nevertheless, there are 8 alternative studies that remain open to enrolment."

Answered by AI

Are applicants younger than fifty-five years of age eligible to join this experiment?

"According to the enrolment requirements, this clinical trial is limited to individuals between 18 and 99 years of age. For minors and seniors who are not eligible for this study, there exist two separate trials that cater specifically to those under 18 and five distinct studies targeting patients above 65."

Answered by AI
~66 spots leftby Jul 2024